.svg.png){kind=icon}
Global expansion marks a major step for preventative health leader as demand grows for proactive screening technology
London, United Kingdom - 24 November – Prenuvo, the company leading proactive whole body MRI imaging for the early detection of cancer and other diseases, today announced the opening of its first UK clinic in London's Fitzrovia district. The expansion marks a significant milestone for the company as it brings comprehensive preventative screening beyond North America and Australia for the first time, having now completed more than 150,000 scans across 27 clinics globally.
Located at 32-36 Great Portland Street situated between London's medical district and shopping district, the two-storey clinic offers the UK and European residents access to advanced whole-body MRI technology that can help identify potential health concerns often before symptoms appear.
The London clinic opening comes at a critical moment as the UK faces significant healthcare challenges, with NHS England data revealing historic pressures with more than 7.6 million people waiting for diagnostic tests. Prenuvo’s entry into the UK offers individuals a proactive option to gain comprehensive and timely health insights to support their health
“When we founded Prenuvo, we believed early detection could fundamentally change the trajectory of healthcare,” said Andrew Lacy, Founder and CEO of Prenuvo. “Opening in London brings that vision to one of the world’s most important medical hubs. People across the UK are looking for personalised insight and a health assessment that goes far deeper than a standard physical, and Prenuvo is proud to offer an approach that delivers both—today.”
Rather than waiting for symptoms to emerge, Prenuvo's technology is designed to identify potential health concerns – including most solid tumour as early as stage 1, brain aneurysms, metabolic disorders, and hundreds of other conditions – all without radiation and contrast, in under an hour. Based on internal data analysis, approximately 1 in 20 Prenuvo scans alerts patients to potentially life-saving diagnoses*
“Opening Prenuvo in the UK is a tremendous privilege and responsibility,” says Dr. Tahreema Matin, DPhil, MBBS, AICSM, BSc(HONS), FRCR, UK Medical Director, Prenuvo. “The clinical opportunity here is significant. Detecting a tumour at an earlier stage generally allows for different treatment options and potentially better outcomes. What we're offering is comprehensive, high-resolution MRI across the entire body in 45 minutes, interpreted by consultant radiologists who specialise in whole-body imaging. We are honoured to serve UK patients with detailed, timely insights to help them take a more proactive approach to health.”
The Prenuvo Whole Body Scan
Prenuvo's advanced approach to screening is based on 15+ years of clinical practice and the company holds the world's largest dataset of whole-body MRI. The comprehensive screening offers:
- 45-minute scan – Fast, non-invasive imaging in a comfortable open-bore MRI machine
- No radiation or contrast – Safe screening without the risks associated with ionising radiation or contrast agents
- Whole-body scan at £2,499 – Prenuvo’s most comprehensive scan that assesses the anatomy, including major organs and spine
- 500+ conditions – Including most solid tumours (which can be detected as early as stage 1), brain aneurysms, metabolic disorders, spinal degeneration, autoimmune conditions, cysts, and more
- Specialised radiologist interpretation – Every scan is thoroughly reviewed by radiologists with specialised expertise in whole-body MRI
The London clinic launch represents the first phase of Prenuvo's European growth strategy, with the company evaluating additional European cities for future expansion.
For more information on Prenuvo's London clinic and to book a scan appointment, visit prenuvo.com.
About Prenuvo
Prenuvo makes proactive health screening seamless and more widely accessible. Combining advanced technology with radiation-free and non-invasive whole body scans, Prenuvo’s patient-centric design is optimised to assess the body holistically, providing individuals with a comprehensive overview of their health in under 60 minutes. Prenuvo’s exclusively-affiliated Radiology group partners consist of 100+ radiologists that help risk-stratify each patient report, keeping in mind healthcare complexities from the patient’s perspective, the treating clinician’s perspective, and the healthcare system’s perspective.
Prenuvo clinics are currently open in New York, Buffalo, Redwood City, Los Angeles, Pasadena, Irvine, San Diego, Scottsdale, Dallas, Houston, Denver, Chicago, Las Vegas, Boca Raton, St. Petersburg, Miami, Philadelphia, Bethesda (DC metro area), Atlanta, Vancouver, Seattle, and at the Hercules Research Center in Boston, and Minneapolis and an international clinic in Melbourne, Australia.Learn more at www.prenuvo.com.
Prenuvo is backed by leading venture capital firms and investors in health, fitness and category-defining consumer brands such as Felicis [investors in Fitbit (IPO), Guardant Health (IPO) and Ring (acq. by Amazon)], 23AndMe CEO Anne Wojcicki, Xavier Niel, Nest founder Tony Fadell, Eric Schmidt, Cindy Crawford, and Lasker award recipient Dr. Timothy A. Springer.
*Based on internal data analysis, 5% of Prenuvo scans have helped detect a potentially life-saving condition. This reflects, in particular, the combined prevalence of radiologically-suspected pre-cancerous/cancerous findings or brain-aneurysms in our WB-MRI screening practices.
